Vestal Point Capital’s Prime Medicine PRME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,070,000
Closed -$4.14M 87
2024
Q3
$4.14M Buy
1,070,000
+620,000
+138% +$2.4M 0.31% 51
2024
Q2
$2.31M Buy
450,000
+90,000
+25% +$463K 0.17% 55
2024
Q1
$2.52M Buy
360,000
+339,694
+1,673% +$2.38M 0.21% 50
2023
Q4
$180K Buy
+20,306
New +$180K 0.02% 47